Case File
efta-efta01788842DOJ Data Set 10CorrespondenceEFTA Document EFTA01788842
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01788842
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Barrett, Paul S
Sent:
Monday, April 25, 2011 5:53 PM
To:
Jeffrey Epstein
Subject:
RE: GS
Greek Govies at 57 now. E=R up 7%. So total return would have been -6% including carry.
EURCHF: you would have been up 1%.<=span>
I also recommended buying Dec11 corn in mid march wh=ch is now up 19%
&=bsp;
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
40W 57th=Street, 33rd Floor, New York, NY 10019
From: </=> Jef=rey Epstein Imailto:[email protected]
Sent: Monday, Apri= 25, 2011 12:19 PM
To: Barrett, Paul S
Subject: Re: GS=o:p>
ALSO PLEASE TELL ME WHERE =HE GREEK BONDS THAT YOU WANTED TO BUY AT 67 ARE TRADING.. AND THE SWIS=
EURO.. THANKS
On Mon, Apr 25, 11 at 11:06 AM, Barrett, Paul S
<mailto:
EFTA_R1_00113826
EFTA01788842
OK &11; will roll it
Also have 30,000 GS fixing on Friday. Do y=u want to roll that tranche as well?
=span style=ifont-size:11.0ptcolor:#1F497D1> </=>
Paul Barrett, CFA
Managing Director
Global Investment Opport=nities Group
JPMorgan Private Bank
40W 57th Street, 33rd Floor, New York, NY 10019
F)=/span> target=> =/p>
From= Jeffrey Epstein [mailto:[email protected]]
Sent: Monday, April 25, 2011 11:04 AM
To: =arrett, Paul S
Subject: Re: GS yes
On Mon, Apr 25, 201= at 11:03 AM, Barrett, Paul S
<mailto:paul.s.barrett@jpm=rgan.com» wr=te:
Hilÿrey
We ha=e a total return swap on 20,000 GS fixing today at 4pm (initial px was $16=.42/share). Do you want to roll it?
Stock is at 151.40 right now. JPMSI px target o= 175.00
&=bsp;
2
EFTA_R1_001 13827
EFTA01788843
Let me=know.
&nb=p;
Paul
</=:p>
Paul Barrett, CFA=/p>
Managing Director
Global Investment Opportunit=es Group
JPMorgan Private Bank
40W 57th Street, 33rd Floor, New York, NY 10O19
=idly>
This email is confidential and subject to important disc=aimers and conditions including on offers for the purchase or
sale of secu=ities, accuracy and completeness of information, viruses, confidentiality,=legal privilege, and legal entity
disclaimers, available at http://=ww.jpmorgan.com/pages/disclosures/email.
<=div>
The information contained in this communication =s confidential, may be attorney-client privileged, may constitute
in=ide information, and is intended only for the use of the addressee. 1= is the property of Jeffrey Epstein Unauthorized
use, disclosure or=copying of this communication or any part thereof is strictly prohibite= and may be unlawful. If you
have received this communication in e=ror, please notify us immediately by return e-mail or by e-mail to
[email protected], and destroy this communication and all copies thereof, in=luding all attachments. copyright
-all rights reserved
This email is confÞntial and subject to important disclaimers and conditions including on oþrs for the purchase or
sale of securities, accuracy and completeness of =nformation, viruses, confidentiality, legal privilege, and legal entity
di=claimers, available at http://www.jpmorgan.com/pages/disclosure=/email
<http://www.jpmorgan.com/pages/disdo=ures/email> .
3
EFTA_R1_001 13828
EFTA01788844
The information contained in this =ommunication is confidential, may be attorney-client privileged, may
the use of the Ýressee. It is the property of Jeffrey Epstein Unauthorized use,=disclosure or copying of this
communication or any part thereof is stri=tly prohibited and may be unlawful. If you have received this comm=nication
in error, please notify us immediately by return e-mail or by =-mail to jeevÊ[email protected]
<mailto:[email protected]> , and destroy this communication and all copies t=ereof, including all attachments.
copyright -all rights reserved=/O:p>
This email is confidential and subject to import=nt disclaimers and conditions including on offers for the purchase or
sale=of securities, accuracy and completeness of information, viruses, confiden=iality, legal privilege, and legal entity
disclaimers, available at http:/=www.jpmorgan.com/pages/disclosures/email.
4
EFTA_R1_00113829
EFTA01788845
Technical Artifacts (6)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Email
[email protected]URL
http://=ww.jpmorgan.com/pages/disclosures/emailURL
http://www.jpmorgan.com/pages/disclosure=/emailURL
http://www.jpmorgan.com/pages/disdo=ures/emailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.